D62 D63
Conditions
Interventions
Group 1: Four study periods were defined (Fig. S1). The first evaluation period (I), July to September 2014, was used as baseline comparator. no education of physicians (historical cohort)
Group 2: F
Sponsors
Universitätsklinikum Greifswald
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients of the following departments were enrolled: surgical departments (general, trauma, orthopedics, neurosurgery, urology, gynecology and obstetrics, surgical intensive care) and medical departments (gastroenterology, pulmonology, nephrology, cardiology, hemato-oncology, medical intensive care).
Exclusion criteria
Exclusion criteria: red blood cell exchange transfusion; missing Hb value within 24h before transfusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint was the change of median pretransfusional Hb-values between evaluation periods. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints were changes in the absolute number of transfused red blood cell concentrates in relation to the number of treated patients, and changes in numbers of red blood cell concentrate-transfusions with a pretransfusional Hb-value of the patient of >10 g/dl. Safety endpoints were the rate of documented in-hospital acute coronary syndrome, all-cause in-hospital mortality, and the length of in-hospital stay. | — |
Countries
Germany
Contacts
Public ContactAndreas Greinacher
Abteilung TransfusionsmedizinUniversitätsmedizin Greifswald
Outcome results
None listed